Innoviva (INVA) Cash & Equivalents (2010 - 2026)
Innoviva (INVA) reported Cash & Equivalents of $570.39 million for Q2 2026, up 43.5% from $397.53 million a year earlier but down 5.4% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Innoviva posted Cash & Equivalents of $550.94 million, up 80.7% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 17.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $304.96 million in FY2024 (+57.6%), $193.51 million in FY2023 (-33.5%), $291.05 million in FY2022 (+44.4%) and $201.53 million in FY2021 (-18.2%).
- Five-year quarterly Cash & Equivalents spans a low of $135.12 million in Q3 2021 and a high of $603.09 million in Q1 2026.
- Year over year, Cash & Equivalents has now increased in each of the last seven quarters, with growth averaging 73.7% over the last seven quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2022 (growth of 555.4%); the low point was Q3 2021 (a decline of 71.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $603.09 million (Q1 2026), $550.94 million (Q4 2025) and $476.51 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Innoviva | 1.49 Bn | -801.70 Mn | 90.62 Mn | 570.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 570.39 Mn |
| Mar 31, 2026 | 603.09 Mn |
| Dec 31, 2025 | 550.94 Mn |
| Sep 30, 2025 | 476.51 Mn |
| Jun 30, 2025 | 397.53 Mn |
| Mar 31, 2025 | 319.09 Mn |
| Dec 31, 2024 | 304.96 Mn |
| Sep 30, 2024 | 260.63 Mn |
| Jun 30, 2024 | 217.00 Mn |
| Mar 31, 2024 | 178.36 Mn |
| Dec 31, 2023 | 193.51 Mn |
| Sep 30, 2023 | 180.00 Mn |
| Jun 30, 2023 | 173.03 Mn |
| Mar 31, 2023 | 144.05 Mn |
| Dec 31, 2022 | 291.05 Mn |
| Sep 30, 2022 | 300.79 Mn |
| Jun 30, 2022 | 283.58 Mn |
| Mar 31, 2022 | 216.80 Mn |
| Dec 31, 2021 | 201.53 Mn |
| Sep 30, 2021 | 135.12 Mn |
API Access
Innoviva Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();